Genalyte, Inc. a life sciences company developing and commercializing innovative next-generation multiplexing technology. The Company has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids. The Maverick Detection System performs real-time detection of macromolecules in crude samples using biologically functionalized silicon photonic biosensors lithographically printed on disposable silicon chips. These biosensors are individually functionalized with unique probe molecules and are individually interrogated making highly multiplexed analysis possible.
Latest funding size
Time since last funding
|about 1 year|
|BioMed Realty Ventures, Khosla Ventures, Redmile Group, Claremont Creek Ventures, CLI Ventures|